

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions
Details : Parecoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 19, 2024
Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain
Details : Parecoxib is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Emergence Delirium.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 14, 2010
Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Xianwei Zhang
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Parecoxib Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 23, 2010
Lead Product(s) : Parecoxib Sodium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Xianwei Zhang
Deal Size : Inapplicable
Deal Type : Inapplicable
